Exceptional Response to Pembrolizumab in a Metastatic, Chemotherapy/Radiation-Resistant Ovarian Cancer Patient Harboring a PD-L1-Genetic RearrangementRegression of CD274-Mutated Tumor with Pembrolizumab
Journal article published in 2018 by
Stefania Bellone,
Natalia Buza,
Jungmin Choi 
,
Luca Zammataro,
Laurie Gay,
Julia Elvin,
David L. Rimm,
Yuting Liu,
Elena S. Ratner,
Peter E. Schwartz
,
Luca Zammataro,
Laurie Gay,
Julia Elvin,
David L. Rimm,
Yuting Liu,
Elena S. Ratner,
Peter E. Schwartz
